Flavonol and flavone intake and the risk of intermittent claudication in male smokers

European Journal of Epidemiology

Volumn 19, Issue 4, 2004, Pages 305-311

  Hirvonen, Tero ^a   Törnwall, Markareetta E ^a   Pietinen, Pirjo ^a   Korhonen, Pasi ^a   Albanes, Demetrius ^b   Virtamo, Jarmo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antioxidants; Cohort studies; Flavonoids; Intermittent claudication

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; FLAVONE; FLAVONOL; FLAVONOID; FLAVONOL DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DIETARY INTAKE; FOLLOW UP; FOOD INTAKE; HUMAN; INTERMITTENT CLAUDICATION; MALE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; VALIDATION PROCESS; VEGETABLE; VITAMIN INTAKE; WINE; COHORT ANALYSIS; DIET; DRINKING BEHAVIOR; FINLAND; MIDDLE AGED; SMOKING;

AGED; ALCOHOL DRINKING; COHORT STUDIES; DIET; FINLAND; FLAVONOIDS; FLAVONOLS; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; SMOKING; VEGETABLES; WINE;

EID: 3242884153     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000024699.81170.07     Document Type: Article

References (36)

1. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
2. De Whalley CV, Rankin SM, Hoult JRS, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990; 39: 1743-1750.
3. Kandaswami C, Middleton E. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994; 366: 351-376.
4. Aviram M, Fuhrman B. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 1998; 137: S45-S50.
5. Zeng LH, Wu J, Fung B, Tong JH, Mickle D, Wu TW. Comparative protection against oxyradicals by three flavonoids on cultured endothelial cells. Biochem Cell Biol 1997; 75: 717-720.
6. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 1998; 128: 593-597.
7. Jansen KPLTM, Mensink RP, Cox FJJ, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998; 67: 255-262.
8. McAnlis GT, McEneny J, Pearce J, Young IS. Absorption and antioxidant effects of quercetin from onions, in man. Eur J Clin Nutr 1999; 53: 92-96.
9. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
10. Knekt P, Järvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: A cohort study. Br Med J 1996; 312: 478-481.
11. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996; 125: 384-389.
12. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999; 149: 943-949.
13. Hirvonen T, Pietinen P, Virtanen M, et al. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology 2001; 12: 62-67.
14. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 1996; 156: 637-642.
15. Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997; 65: 1489-1494.
16. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000; 31: 2301-2306.
17. Donnan PT, Thomson M, Fowkes FGR, Prescott RJ, Housley E. Diet as risk factor for peripheral arterial disease in the general population: The Edinburgh Artery Study. Am J Clin Nutr 1993; 57: 917-921.
18. Katsoyanni K, Skalkidis Y, Petridou E, Polychronopolou-Trichopolou A, Willett W, Trichopoulos D. Diet and peripheral arterial occlusive disease: The role of poly-, mono-, and saturated fatty acids. Am J Epidemiol 1991; 133: 24-31.
19. Törnwall ME, Virtamo J, Haukka JK, Aro A, Albanes D, Huttunen J. Prospective study of diet, lifestyle, and intermittent claudication in male smokers. Am J Epidemiol 2000; 151: 892-901.
20. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, Boeing H, Hofman A, Witteman JCM. Dietary antioxidants and peripheral arterial disease. Am J Epidemiol 2001; 154: 145-149.
21. The ATBC Cancer Prevention Study Group. The α-Tocopherol, β-Carotene Lung Cancer Study: Design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1-10.
22. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27: 645-658.
23. Kattermann R, Jaworek D, Möller G, et al. Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 1984; 22: 245-251.
24. Kostner GM. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976; 22: 695.
25. Pietinen L, Hartman AM, Haapa E, et al. Reproducibility and validity of dietary assessment instruments, I: A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988; 128: 655-666.
26. Hertog MGL, Hollman PC, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 1992; 40: 2379-2383.
27. Hertog MGL, Hollman PC, van de Putte P. Content of potentially anticarcinogenic flavonoids in tea infusions, wines, and fruit juices. J Agric Food Chem 1993; 41: 1242-1246.
28. Häkkinen SH, Kärenlampi SO, Heinonen IM, Mykkänen HM, Törrönen AR. Content of the flavonols quercetin, myricetin and kaempherol in 25 edible berries. J Agric Food Chem 1999; 47: 2274-2279.
29. Willett WC, Stampfer MJ. Total energy intake - implications for epidemiologic analyses. Am J Epidemiol 1986; 124: 17-27.
30. Törnwall ME, Virtamo J, Haukka JK, Aro A, Albanes D, Huttunen JK. The effect of alpha-tocopherol (vitamin E) and beta-carotene supplementation on the incidence of intermittent claudication in male smokers. Arterioscler Thromb Vasc Biol 1997; 17: 3475-3480.
31. Leng GC, Fowkes FGR. The Edinburg claudication questionnaire: An improved version of the WHO/Rose questionnaire for use in epidemiologic surveys. J Clin Epidemiol 1992; 45: 1101-1109.
32. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Goldbourt U. Epidemiology of intermittent claudiaction in middle-aged men. Am J Epidemiol 1994; 140: 418-430.
33. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456.
34. Knekt P, Reunanen A, Järvinen R, Seppänen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal study. Am J Epidemiol 1994; 139: 180-189.
35. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and beta-carotene and risk of death in middle-aged men: The Western Electric study. Am J Epidemiol 1995; 142: 1269-1278.
36. Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56: 317-333.